Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial

Autor: Duchesne, Gillian M, Woo, Henry H, Bassett, Julie K, Bowe, Steven J, D'Este, Catherine, Frydenberg, Mark, King, Madeleine, Ledwich, Leo, Loblaw, Andrew, Malone, Shawn, Millar, Jeremy, Milne, Roger, Smith, Rosemary G, Spry, Nigel, Stockler, Martin, Syme, Rodney A, Tai, Keen Hun, Turner, Sandra
Zdroj: In The Lancet Oncology June 2016 17(6):727-737
Databáze: ScienceDirect